SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-22-005920
Filing Date
2022-03-11
Accepted
2022-03-11 07:30:36
Documents
63
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K plxp20211231_10k.htm   iXBRL 10-K 1497594
2 EXHIBIT 4.6 ex_342635.htm EX-4.6 8428
3 EXHIBIT 21.1 ex_342636.htm EX-21.1 1637
4 EXHIBIT 23.1 ex_342637.htm EX-23.1 2483
5 EXHIBIT 31.1 ex_342638.htm EX-31.1 12754
6 EXHIBIT 31.2 ex_342639.htm EX-31.2 12273
7 EXHIBIT 32.1 ex_342640.htm EX-32.1 6558
13 logo.jpg GRAPHIC 4206
  Complete submission text file 0001437749-22-005920.txt   6273437

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA plxp-20211231.xsd EX-101.SCH 49452
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20211231_cal.xml EX-101.CAL 53055
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20211231_def.xml EX-101.DEF 395230
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20211231_lab.xml EX-101.LAB 371825
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20211231_pre.xml EX-101.PRE 416797
57 EXTRACTED XBRL INSTANCE DOCUMENT plxp20211231_10k_htm.xml XML 781758
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36351 | Film No.: 22731133
SIC: 2834 Pharmaceutical Preparations